Recruiting
Phase 2

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Sponsor:

ECOG-ACRIN Cancer Research Group

Code:

NCT06319027

Conditions

Glioblastoma, IDH-Wildtype

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

Fluciclovine F18

Gadolinium-Chelate

Magnetic Resonance Spectroscopy

Positron Emission Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information